e Learned from the Failure of Large Clinical Trials 事与愿违.pptVIP

下载本文档

1
0
约1.62万字
约 40页
2018-02-11 发布于江西
举报
版权申诉

e Learned from the Failure of Large Clinical Trials 事与愿违.ppt

1、本文档共40页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

e Learned from the Failure of Large Clinical Trials 事与愿违

What We have Learned from the Failure of Large Clinical Trials? 事与愿违的大型临床试验结果告诉了我们什麽? HUI Rutai 惠汝太 Beijing FuWai Hospital, China 北京阜外医院高血压中心主任 prioritizes target levels of some risk factors: plasma sugar blood presure cholestrol Womens Health Initiative RCT revealed that hormone-replacement therapy, which reduces LDL cholesterol levels, increased the risk of cardiovascular disease. (Anderson et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Womens Health Initiative Randomized Controlled Trial. JAMA 2004;291:1701-1712) ENHANCE ENHANCE: Effect of Combination Ezetimibe and High-Dose Simvastatin versus Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia Kastelein et al: NEJM 2008,358:1431-1443; Correction: NEJM 2008,358:1977 ENHANCE showed that ezetimibe did not reduce the progression of arteriosclerosis when combined with simvastatin, as compared with simvastatin alone, even though the combination did result in a greater reduction of LDL cholesterol. Kastelein et al: NEJM 2008,358:1431-1443; Correction: NEJM 2008,358:1977 Post-trial Study UKPDS (UK Protective Diabetes Study) Type-2 DM: low plasma glucose, Reduction in microvascular complications. Whether the therapy can reduce macrovascular complications? 降糖治疗试验停止后，持续随访10年的结果 Holman et al NEJM 2008:359: Any DM-related Endpoints： sudden death， death from hyperglycemia, hypoglycemia, fatal, non-fatal MI, angina, heart failure, fatal, non-fatal Stroke, renal failure, amputation, vitreous hemorrhage, retinal photo-coagulation, blindness in one eye, hyperglycemia, Hypoglycemia. Microvascular disease: vitreous (玻璃体)hemorrhage, retinal photo-Coagulation(视网膜光凝术 ), renal failure,